205 related articles for article (PubMed ID: 27719643)
1. Curcumin: An Effective Inhibitor of Interleukin-6.
Ghandadi M; Sahebkar A
Curr Pharm Des; 2017; 23(6):921-931. PubMed ID: 27719643
[TBL] [Abstract][Full Text] [Related]
2. Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways.
Chen M; Hu DN; Pan Z; Lu CW; Xue CY; Aass I
Exp Eye Res; 2010 Mar; 90(3):437-43. PubMed ID: 20026325
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
5. The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection.
Wessler S; Muenzner P; Meyer TF; Naumann M
Biol Chem; 2005 May; 386(5):481-90. PubMed ID: 15927892
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations.
Nahar PP; Slitt AL; Seeram NP
J Med Food; 2015 Jul; 18(7):786-92. PubMed ID: 25490740
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation.
Hidaka H; Ishiko T; Furuhashi T; Kamohara H; Suzuki S; Miyazaki M; Ikeda O; Mita S; Setoguchi T; Ogawa M
Cancer; 2002 Sep; 95(6):1206-14. PubMed ID: 12216086
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: a modulator of inflammatory signaling pathways in the immune system.
Kahkhaie KR; Mirhosseini A; Aliabadi A; Mohammadi A; Mousavi MJ; Haftcheshmeh SM; Sathyapalan T; Sahebkar A
Inflammopharmacology; 2019 Oct; 27(5):885-900. PubMed ID: 31140036
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets.
Aggarwal BB; Sung B
Trends Pharmacol Sci; 2009 Feb; 30(2):85-94. PubMed ID: 19110321
[TBL] [Abstract][Full Text] [Related]
10. Biological actions of curcumin on articular chondrocytes.
Henrotin Y; Clutterbuck AL; Allaway D; Lodwig EM; Harris P; Mathy-Hartert M; Shakibaei M; Mobasheri A
Osteoarthritis Cartilage; 2010 Feb; 18(2):141-9. PubMed ID: 19836480
[TBL] [Abstract][Full Text] [Related]
11. Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium.
Lim R; Barker G; Wall CA; Lappas M
Mol Hum Reprod; 2013 Jul; 19(7):451-62. PubMed ID: 23475986
[TBL] [Abstract][Full Text] [Related]
12. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
13. Curcumin attenuates inflammatory responses by suppressing TLR4-mediated NF-κB signaling pathway in lipopolysaccharide-induced mastitis in mice.
Fu Y; Gao R; Cao Y; Guo M; Wei Z; Zhou E; Li Y; Yao M; Yang Z; Zhang N
Int Immunopharmacol; 2014 May; 20(1):54-8. PubMed ID: 24508537
[TBL] [Abstract][Full Text] [Related]
14. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes.
Schulze-Tanzil G; Mobasheri A; Sendzik J; John T; Shakibaei M
Ann N Y Acad Sci; 2004 Dec; 1030():578-86. PubMed ID: 15659840
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates CFA induced thermal hyperalgesia by modulation of antioxidant enzymes and down regulation of TNF-α, IL-1β and IL-6.
Singh AK; Vinayak M
Neurochem Res; 2015 Mar; 40(3):463-72. PubMed ID: 25479948
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets.
Cho JW; Lee KS; Kim CW
Int J Mol Med; 2007 Mar; 19(3):469-74. PubMed ID: 17273796
[TBL] [Abstract][Full Text] [Related]
17. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity.
Biswas SK; McClure D; Jimenez LA; Megson IL; Rahman I
Antioxid Redox Signal; 2005; 7(1-2):32-41. PubMed ID: 15650394
[TBL] [Abstract][Full Text] [Related]
18. Curcumin attenuates DNB-induced murine colitis.
Salh B; Assi K; Templeman V; Parhar K; Owen D; Gómez-Muñoz A; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G235-43. PubMed ID: 12637253
[TBL] [Abstract][Full Text] [Related]
19. "Spicing up" of the immune system by curcumin.
Jagetia GC; Aggarwal BB
J Clin Immunol; 2007 Jan; 27(1):19-35. PubMed ID: 17211725
[TBL] [Abstract][Full Text] [Related]
20. BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway--A comparative study with curcumin.
Mohankumar K; Sridharan S; Pajaniradje S; Singh VK; Ronsard L; Banerjea AC; Somasundaram DB; Coumar MS; Periyasamy L; Rajagopalan R
Biomed Pharmacother; 2015 Aug; 74():178-86. PubMed ID: 26349982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
